SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-24-134195
Filing Date
2024-05-08
Accepted
2024-05-08 16:06:47
Documents
93
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d732534d10q.htm   iXBRL 10-Q 1179077
2 EX-31.1 d732534dex311.htm EX-31.1 10782
3 EX-31.2 d732534dex312.htm EX-31.2 10797
4 EX-32.1 d732534dex321.htm EX-32.1 5035
5 EX-32.2 d732534dex322.htm EX-32.2 5050
  Complete submission text file 0001193125-24-134195.txt   7357500

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cprx-20240331.xsd EX-101.SCH 75371
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20240331_cal.xml EX-101.CAL 62670
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20240331_def.xml EX-101.DEF 261783
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20240331_lab.xml EX-101.LAB 474908
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20240331_pre.xml EX-101.PRE 400646
97 EXTRACTED XBRL INSTANCE DOCUMENT d732534d10q_htm.xml XML 1220397
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 24925967
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)